Graphene based aptasensor for glycated albumin in diabetes mellitus diagnosis and monitoring

Biosens Bioelectron. 2016 Aug 15:82:140-5. doi: 10.1016/j.bios.2016.04.015. Epub 2016 Apr 7.

Abstract

We selected and modified DNA aptamers specifically bound glycated human serum albumin (GHSA), which is an intermediate marker for diabetes mellitus. Our aptamer truncation study indicated that the hairpin-loop structure with 23 nucleotides length containing triple G-C hairpins and 15-nucleotide loop, plays an important role in GHSA binding. Fluorescent quenching graphene oxide (GO) and Cy5-labeled G8 aptamer were used in this study to develop simple and sensitive graphene based aptasensor for GHSA detection. The limit of detection (LOD) of our aptasensor was 50 μg/mL, which was lower than other existing methods. In addition, with the nuclease resistance system, our GHSA detection platform could also be used in clinical samples. Importantly, our approach could significantly reveal the higher levels of GHSA concentrations in diabetes than normal serums. These indicate that our aptasensor has a potential for diagnosis and monitoring of diabetes mellitus.

Keywords: Aptamer; Aptasensor; Diabetes mellitus; Glycated human serum albumin; Graphene oxide.

Publication types

  • Evaluation Study

MeSH terms

  • Aptamers, Nucleotide / chemistry*
  • Base Sequence
  • Biosensing Techniques / methods*
  • Carbocyanines / chemistry
  • Diabetes Mellitus / blood
  • Diabetes Mellitus / diagnosis*
  • Fluorescent Dyes / chemistry
  • Glycated Serum Albumin
  • Glycation End Products, Advanced
  • Graphite / chemistry*
  • Humans
  • Limit of Detection
  • Oxides / chemistry
  • Serum Albumin / analysis*

Substances

  • Aptamers, Nucleotide
  • Carbocyanines
  • Fluorescent Dyes
  • Glycation End Products, Advanced
  • Oxides
  • Serum Albumin
  • cyanine dye 5
  • Graphite
  • Glycated Serum Albumin